|
|
|
| Webinar: Critical Imaging Risks in GLP-1 and Neurology Studies: What You Need to Know | Clinical trials in GLP-1 and neurology rely increasingly on imaging, but challenges often go unaddressed. This webinar covers early indicators of imaging issues, preclinical insights, expanding imaging requirements, and hidden risks. Attendees will learn how early identification of imaging risks, preclinical data, and strategic planning can mitigate delays, improve trial efficiency, and ensure regulatory compliance. Click here to learn more. |
|
|
|
| Government Contract Advances Walgreens In Clinical Space | From The Editor | By Dan Schell, chief editor, Clinical Leader | Walgreen’s new $25 million deal with BARDA (Biomedical Advanced Research and Development Authority) is a huge win for the pharmacy chain. John Campbell, head of DCTs at Walgreens, explains the study and what could be next for the company regarding its clinical trials division. |
|
|
|
|
| Challenging the Norm: Smaller Partners, Bigger Impact | In our outsourcing industry, it is never an easy decision to select a partner when trying to run complex sequential trials. The need to gain regulatory approval for the treatments you have dedicated yourself to providing, coupled with the need to find a capable, reliable, and fair Contract Research Organization is quite daunting. Discover how a smaller full-service partner may be better suited to see your study through. |
|
|
|
| What Future Laboratory Manuals Should Look Like | Guest Column | By Elena Sinclair, FlexPoint Bio | In the final article of this series on lab manuals, FlexPoint Bio Founder and CEO Elena Sinclair imagines what the perfect lab manual might look like — and how to make it a reality. |
|
|
| Disrupting The Clinical Trial Ecosystem | Article | By Sheila Gwizdak, Halloran Consulting | Clinical research advances healthcare, but access, opportunity, and technology are vital to overcoming barriers and improving outcomes. |
|
|
|
| Top Countries For Rescuing Your Clinical Study | Article | Palleos | When your study is in trouble, choosing the right country can help get it back on track. Here, Palleos Healthcare shares the countries they have experienced with regard to clinical trial rescue. |
|
|
| Factors Affecting Systemic Drug Exposure | Article | Altasciences | The increasing number of drugs on the market leads to a greater potential for DDIs. Determining the extent of the interaction and associated risks is an important safety consideration. |
|
|
|
|
|
CHOOSE YOUR OWN ADVENTURE |
|
|
|
| You're receiving the Wednesday edition of the Clinical Leader newsletter, focusing on Decentralized Trials and Trial Management. To make changes to your newsletter selections, update your topic preferences. - Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
- Clinical Trial Technology (Tuesday)
- Decentralized Trials | Trial Management (Wednesday)
- Outsourcing Models | Regulatory & Compliance (Thursday)
- Clinical Data Management & Analytics | Trial Monitoring (Friday)
Learn more about our personalized newsletters here. |
|
|
| Connect With Clinical Leader: |
|
|
|
